Serological response patterns to assess treatment outcomes in advanced non-small cell lung cancer

This data was collected in the context of our real-world exploratory multi-center cohort study that aimed to determine which STM dynamics recur during treatment in advanced non-small cell lung cancer (NSCLC) patients with disease control three months after start with immune checkpoint inhibitor (ICI)-containing treatment and to explore whether these dynamics retain information on treatment outcomes. Between March 2013 and January 2023, 256 patients were included at two thoracic oncology outpatient clinics in The Netherlands (e.g. the Radboudumc, Nijmegen, The Netherlands, and the Netherlands Cancer Institute, Amsterdam, The Netherlands). In the "Patient characteristics" file, clinincal and tumor characteristics, including survival data, of all included patients can be found. In the "Patient serum tumor marker data" file, serum tumor marker data of all included patients can be found.